Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 2269-2274

  Guan, Xuan ^a,b   Wang, Xiang ^c   Luo, Hao ^d   Wu, Jing ^b   Zhang, Xiao ^a   Wu, Jin ^b  

^a CHENGDU MEDICAL COLLEGE   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d Nursing Department   (China)

Author keywords

Esophageal neoplasms; Genetic association studies; Matrix metalloproteinase 1

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN; MMP1 PROTEIN, HUMAN; MMP3 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ENZYMOLOGY; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84924811022     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892413     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J et al: Global cancer statistics, 2002. Cancer J Clin, 2005; 55: 74–108
2. Klimstra DS: Pathologic prognostic factors in esophageal carcinoma. Semin Oncol, 1994; 21: 425–30
3. Gao YT, McLaughlin JK, Blot WJ et al: Risk factors for esophageal cancer in Shanghai. China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer,1994; 58: 192–96
4. Yang L, Parkin DM, Li L et al: Time trends in cancer mortality in China: 1987-1999. Int J Cancer, 2003; 106: 771–83
5. Stoner GD, Gupta A: Etiology and chemoprevention of esophageal squa-mous cell carcinoma. Carcinogenesis, 2001; 22: 1737–46
6. Launoy G, Milan CH, Faivre J et al: Alcohol, tobacco and oesophageal cancer: efects of the duration of consumption, mean intake and current and former consumption. Br J Cancer, 1997; 75: 1389–96
7. Parsons SL, Watson SA, Brown PD et al: Matrix metalloproteinases. Br J Surg, 1997; 84: 160–66
8. Murray GI, Duncan ME, O’Neil P et al: Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol, 1998; 185: 256–61
9. Shima I, Sasaguri Y, Kusukawa J et al: Production of matrix metalloprotein-ase-2 and metalloproteinase-3 related to malignant behavior of esopha-geal carcinoma. Cancer, 1992; 70: 2747–53
10. Tanioka Y, Yoshida T, Yagawa T et al: Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in su-perfcial oesophageal cancer. Br J Cancer, 2003; 89: 2116–21
11. Fujimoto T, Parry S, Urbanek M et al: A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter infuences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem, 2002; 277: 6296–302
12. Ye S, Watts GF, Mandalia S et al: Genetic variation in the human strome-lysin promoter is associated with progression of coronary atherosclerosis. Br Heart J, 1995; 73: 209–15
13. Zhang B, Ye S, Herrmann SM et al: Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation, 1999; 99: 1788–94
14. Ghilardi G, Biondi ML, Caputo M et al: A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res, 2002; 8: 3820–23
15. Hinoda Y, Okayama N, Takano N et al: Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorec-tal cancer. Int J Cancer, 2002; 102: 526–29
16. Hirata H, Naito K, Yoshihiro S, et al: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer, 2003; 106: 372–74
17. Sugimoto M, Yoshida S, Kennedy S et al: Matrix metalloproteinase-1 and -9 promoter polymorphisms and endometrial carcinoma risk in a Japanese population. J Soc Gynecol Investig, 2006; 13: 523–29
18. Jin X, Kuang G, Wei LZ et al: No association of the matrix metalloproteinase 1 promoter polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in northern China. World J Gastroenterol, 2005; 11: 2385–89
19. Zhang J, Jin X, Fang S et al: The functional SNP in the matrix metallopro-teinase-3 promoter modifes susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocar-cinoma. Carcinogenesis, 2004; 25: 2519–24
20. Wu J, Zhang L, Luo H et al: Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma. DNA Cell Biol, 2008; 27: 553–57
21. Stephens M, Donnelly P: A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet, 2003; 73: 1162–69
22. Deryugina EI, Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev, 2006; 25: 9–34
23. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2002; 2: 161–74
24. Wilson CL, Matrisian LM: Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol, 1996; 28: 123–36
25. Tetlow LC, Lees M, Woolley DE: Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro. Virchows Arch, 1995; 425: 569–76
26. Johansson N, Ahonen M, Kähäri VM: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci, 2000; 57: 5–15
27. Ye S: Infuence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res, 2006; 69: 636–45
28. Lièvre A, Milet J, Carayol J et al: Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer, 2006; 6: 270
29. Okamoto K, Ishida C, Ikebuchi Y et al: The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. Intern Med, 2010; 49: 887–95
30. Fang S, Jin X, Wang R et al: Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis, 2005; 26: 481–86
31. Krippl P, Langsenlehner U, Renner W et al: The 5A/6A Polymorphism of the Matrix Metalloproteinase 3 Gene Promoter and Breast Cancer. Clin Cancer Res, 2004; 10: 3518–20
32. Lei H, Zaloudik J, Vorechovsky I: Lack of association of the -1171(5A) allele of the MMP3 promoter with breast cancer. Clin Chem, 2002; 48: 798–99
33. Zhang J, Jin X, Fang S et al: The functional SNP in the matrix metallopro-teinase-3 promoter modifes susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocar-cinoma. Carcinogenesis, 2004; 25: 2519–24